Detalhe da pesquisa
1.
The impact of coding germline variants on contralateral breast cancer risk and survival.
Am J Hum Genet
; 110(3): 475-486, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36827971
2.
Simultaneous isolation of hormone receptor-positive breast cancer organoids and fibroblasts reveals stroma-mediated resistance mechanisms.
J Biol Chem
; 299(8): 105021, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423299
3.
HRD related signature 3 predicts clinical outcome in advanced tubo-ovarian high-grade serous carcinoma.
Gynecol Oncol
; 180: 91-98, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38061276
4.
Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patients.
Int J Cancer
; 145(10): 2692-2700, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30927251
5.
Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.
Genet Med
; 19(5): 599-603, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27711073
6.
Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium.
Breast Cancer Res
; 18(1): 98, 2016 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27716369
7.
A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium.
Hum Mol Genet
; 23(7): 1934-46, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24242184
8.
Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families.
Breast Cancer Res Treat
; 158(3): 463-9, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27438779
9.
Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer.
Carcinogenesis
; 36(2): 256-71, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25586992
10.
Common germline polymorphisms associated with breast cancer-specific survival.
Breast Cancer Res
; 17: 58, 2015 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-25897948
11.
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.
Breast Cancer Res
; 17: 18, 2015 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25849327
12.
Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes.
Clin Cancer Res
; 29(16): 3110-3123, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36805632
13.
Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma.
Cancer Cell
; 41(6): 1103-1117.e12, 2023 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37207655
14.
Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53.
bioRxiv
; 2023 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37693555
15.
Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53.
Cell Rep
; 42(12): 113478, 2023 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37991919
16.
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants.
NPJ Breast Cancer
; 9(1): 37, 2023 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37173335
17.
Distinct overlapping sequences at the carboxy-terminus of merlin regulate its tumour suppressor and morphogenic activity.
J Cell Mol Med
; 16(9): 2161-75, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22325036
18.
Lineage-specific silencing of PSAT1 induces serine auxotrophy and sensitivity to dietary serine starvation in luminal breast tumors.
Cell Rep
; 38(3): 110278, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045283
19.
Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications.
Breast Cancer Res
; 13(5): R90, 2011 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21542898
20.
High miR-30 Expression Associates with Improved Breast Cancer Patient Survival and Treatment Outcome.
Cancers (Basel)
; 13(12)2021 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34200751